Eric Olson's most recent trade in Iridium Communications Inc was a trade of 615 Common Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 615 | 142,599 (0%) | 0% | 0 | Common Stock | |
| Sarcos Technology and Robo... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 14,819 | 58,996 | - | 0 | Common Stock | |
| SINTX Technologies Inc | Eric K. Olson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.94 per share. | 22 Apr 2025 | 8,257 | 11,493 (0%) | 0% | 1.9 | 16,013 | Common Stock |
| SINTX Technologies Inc | Eric K. Olson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.95 per share. | 22 Apr 2025 | 3,000 | 3,236 (0%) | 0% | 2.0 | 5,852 | Common Stock |
| SINTX Technologies Inc | Eric K. Olson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 22 Apr 2025 | 3,000 | 14,493 (0%) | 0% | 1.9 | 5,801 | Common Stock |
| SINTX Technologies Inc | Eric K. Olson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 22 Apr 2025 | 236 | 236 (0%) | 0% | 1.7 | 408 | Common Stock |
| SINTX Technologies Inc | Eric K. Olson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 22 Apr 2025 | 7 | 14,500 (0%) | 0% | 2 | 14 | Common Stock |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 676 | 141,983 (0%) | 0% | 0 | Common Stock | |
| Iridium Communications Inc | Eric T. Olson | Director | Sale of securities on an exchange or to another person at price $ 34.03 per share. | 18 Feb 2025 | 4,955 | 137,557 (0%) | 0% | 34.0 | 168,619 | Common Stock |
| Iridium Communications Inc | Eric T. Olson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,750 | 0 | - | - | Stock Option (Right to Buy) | |
| Iridium Communications Inc | Eric T. Olson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.05 per share. | 18 Feb 2025 | 3,750 | 141,307 (0%) | 0% | 7.1 | 26,438 | Common Stock |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 7,130 | 142,512 (0%) | 0% | 0 | Common Stock | |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 626 | 135,382 (0%) | 0% | 0 | Common Stock | |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 594 | 134,755 (0%) | 0% | 0 | Common Stock | |
| Under Armour Inc - Ordinar... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 18,987 | 156,592 (0%) | 0% | 0 | Class C Common Stock | |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 676 | 134,161 (0%) | 0% | 0 | Common Stock | |
| Sarcos Technology and Robo... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 635 | 133,485 (0%) | 0% | 0 | Common Stock | |
| Iridium Communications Inc | Olson T. Eric | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 5,413 | 132,850 (0%) | 0% | 0 | Common Stock | |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 385 | 127,437 (0%) | 0% | 0 | Common Stock | |
| Under Armour Inc - Ordinar... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2023 | 21,613 | 137,605 (0%) | 0% | 0 | Class C Common Stock | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 3.50 per share. | 17 Jul 2023 | 689 | 6,661 (0%) | 0% | 3.5 | 2,412 | Common Stock |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 254 | 126,703 (0%) | 0% | 0 | Common Stock | |
| Sarcos Technology and Robo... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 195,059 | 265,066 | - | 0 | Common Stock | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 2,000 | 7,973 (0%) | 0% | - | Common Stock | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 2,000 | 6,000 | - | - | Restricted Stock Units | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. | 31 Mar 2023 | 623 | 7,350 (0%) | 0% | 2.6 | 1,607 | Common Stock |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 257 | 126,449 (0%) | 0% | 0 | Common Stock | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 35,000 | 35,000 | - | - | Restricted Stock Units | |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 4,042 | 126,192 (0%) | 0% | 0 | Common Stock | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2022 | 44,500 | 44,500 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2022 | 34,000 | 34,000 | - | - | Restricted Stock Units | |
| Sarcos Technology and Robo... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 57,692 | 70,007 | - | 0 | Common Stock | |
| Under Armour Inc - Ordinar... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 20,402 | 115,991 (0%) | 0% | 0 | Class C Common Stock | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. | 01 Apr 2022 | 27,266 | 59,734 (0%) | 0% | 1.1 | 30,538 | Common Stock |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 200,000 | 200,000 | - | - | Restricted Stock Units | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 80,000 | 80,000 | - | - | Restricted Stock Units | |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 4,955 | 122,150 (0%) | 0% | 0 | Common Stock | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 05 Jan 2022 | 2,208 | 0 (0%) | 0% | 3.5 | 7,655 | Common Stock |
| Under Armour Inc - Ordinar... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,314 | 95,588 (0%) | 0% | 0 | Class C Common Stock | |
| Sarcos Technology and Robo... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 12,315 | 12,315 | - | 0 | Common Stock | |
| Under Armour Inc - Ordinar... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 1,315 | 94,274 (0%) | 0% | 0 | Class C Common Stock | |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 39.06 per share. | 07 Jul 2021 | 96 | 117,195 (0%) | 0% | 39.1 | 3,750 | Common Stock |
| Under Armour Inc - Ordinar... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 1,263 | 92,959 (0%) | 0% | 0 | Class C Common Stock | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 01 Jul 2021 | 1,164 | 0 (0%) | 0% | 5.5 | 6,460 | Common Stock |
| Under Armour Inc - Ordinar... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 8,161 | 91,696 (0%) | 0% | 0 | Class C Common Stock | |
| Under Armour Inc - Ordinar... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 1,299 | 83,535 (0%) | 0% | 0 | Class C Common Stock | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 15 Mar 2021 | 3,628 | 3,628 (0%) | 0% | 1.0 | 3,664 | Common Stock |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.47 per share. | 15 Mar 2021 | 3,628 | 0 (0%) | 0% | 9.5 | 34,372 | Common Stock |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 3,628 | 90,697 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 94,000 | 94,000 | - | - | Stock Option (right to buy) | |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 3,362 | 115,838 (0%) | 0% | 0 | Common Stock | |
| Iridium Communications Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 41.63 per share. | 06 Jan 2021 | 1,321 | 117,159 (0%) | 0% | 41.6 | 54,993 | Common Stock |
| Under Armour Inc - Ordinar... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 1,494 | 82,235 (0%) | 0% | 0 | Class C Common Stock | |
| Under Armour Inc - Ordinar... | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 1,630 | 80,741 (0%) | 0% | 0 | Class C Common Stock | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 17 Aug 2020 | 10,787 | 0 (0%) | 0% | 13 | 140,231 | Common Stock |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 17 Aug 2020 | 10,787 | 10,787 (0%) | 0% | 1.0 | 10,895 | Common Stock |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 10,787 | 94,325 | - | - | Stock Option (right to buy) | |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 17 Aug 2020 | 4,963 | 0 (0%) | 0% | 13 | 64,519 | Common Stock |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 17 Aug 2020 | 4,963 | 4,963 (0%) | 0% | 1.0 | 5,013 | Common Stock |
| Syros Pharmaceuticals Inc. | Eric R. Olson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 4,963 | 105,112 | - | - | Stock Option (right to buy) |